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SUMMARY
During dengue type 2 virus (DV) infection of mice a unique cytokine, the cytotoxic factor (CF), is
produced which reproduces the pathological lesions seen in patients of dengue haemorrhagic fever
(DHF). Recently we have observed a CF-like protein in the sera ofDHF cases. The present study
was undertaken to investigate whether DV can stimulate human peripheral blood mononuclear
cells (PBMC) in vitro to produce human CF (hCF). Cultures prepared from PBMC or its enriched
subpopulations were inoculated with 1000 LD50 of DV and controls with normal mouse brain
suspension (NMB). Aliquots of cultures were harvested daily from 24 h to 96 h and their
supernatant (CS) and cells were separated. CS were screened for viral titres and for the presence
ofhCF by cytotoxicity assay, inhibition ELISA, dot blot and Western blot tests using anti-mouse-
CF antibodies. The RNA from the cells was screened in Northern blot and dot blot tests for the
presence ofmRNA for CF. It was observed that hCF appeared in the CS of DV-infected culture of
PBMC and T-enriched cells at 48 h and was present until 96 h; no CF was detected in CS of B cells
or monocyte cultures. The production of hCF was abrogated by pretreatment of the T cells with
anti-CD4 antibodies but not with anti-CD8 antibodies, indicating that hCF was produced by
CD4+ T cells. The Northern blot analysis using oligonucleotide probes prepared on the basis of
amino-terminal sequence of mouse CF, showed presence of mRNA for hCF in PBMC and T cell
cultures. DV replicated in PBMC cultures with peak titres at 48 h. The findings of the present study
demonstrate that DV-induced hCF is produced by human T cells.
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INTRODUCTION
Increased vascular permeability, thrombocytopenia, cerebral
oedema and alterations in blood leucocytes are the cardinal
features of dengue haemorrhagic fever/shock syndrome (DHF/
DSS). The pathogenesis of the disease is not fully known. A
unique cytokine, the cytotoxic factor (CF) is produced by the T
lymphocytes ofdengue type 2 virus (DV)-infected mouse spleen
[1]. It has recently been shown that CF is a pathogenesis-
associated protein, capable of reproducing all the pathological
lesions in mice that are seen in cases ofhuman dengue [2-4]. CF
is a molecule of 22-25 kD on SDS-PAGE with an isoelectric
point ofpH 6-5. The N-terminal sequence of 19 amino acids of
CF does not match with any other known cytokine or dengue
virus-specific proteins [5]. Oligonucleotide probes derived from
this sequence show the presence ofmRNA for CF in the spleen
cells of DV-infected mice by Northern blot test. The present
study has been planned to investigate if human peripheral
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blood leucocytes can be stimulated by DV in vitro to produce
human CF (hCF). This is the first study to describe production
of DV-induced CF by human CD4+ T cells.
MATERIALS AND METHODS
Mice
The study was carried out on inbred Swiss albino mice aged 2-3
months, obtained from the colony maintained in this
Department.
Virus
Dengue type 2 virus (DV), strain P23085, obtained from the
National Institute of Virology (Pune, India), was used in the
form of infected mouse brain suspension [6]. Similarly prepared
normal mouse brain homogenate (NMB) was used in controls.
Virus was titrated by intracerebral (i.c.) inoculation of groups
of mice in serial 10-fold dilutions of the supernatants of
peripheral blood mononuclear cell (PBMC) cultures collected
at different times post-infection. The virus titre was calculated
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by the method of Reed & Muench [7] and expressed as logl0
LD50 per millilitre of the culture supernatant.
Preparation ofPBMC
Peripheral venous blood was collected from the authors (R.M.
and U.C.C. alternately) in a heparinized tube. The leucocyte-
rich plasma was removed and the PBMC consisting of mono-
cytes and lymphocytes were separated as described earlier [8].
Briefly, the leucocyte-rich plasma was layered over Lympho-
prep, density 1 077 g/ml (Nyegaard & Co. As., Oslo, Norway)
and centrifuged at room temperature at 400 g for 30 min. The
interface layer was collected, and the cells were washed three
times with Hanks' basal salt solution (HBSS). The cells were
counted and smears were stained with Giemsa stain to study
cell morphology.
Preparation ofenriched population of T and B cells
Washed PBMC were passed through glass wool columns to
remove monocytes and were then filtered through nylon wool
columns to obtain an enriched subpopulation of T and B cells
[9]. The cells were counted and 1 x 106 cells/ml were cultured
for different assay.
Preparation of monocyte-enriched cells
The PBMC were suspended in Eagle's minimum essential
medium (MEM) containing 5% fetal calf serum (FCS), layered
in 4-cm Petri dishes (Nunclon, Nunc, Denmark) and incubated
at 37°C in an atmosphere of 5% CO2 in air. After 2 h the Petri
dishes were shaken and the non-adherent cells decanted. The
process was repeated three times using fresh HBSS every time.
Most of the glass-adherent cells were phagocytic, as shown by
phagocytosis of latex particles [8]. These cells were therefore
considered as monocytes in the present study.
Treatment of T cells with CD antibodies and complement
The enriched T cells were treated with mouse anti-human CD4
or CD8 MoAbs (Dako A/S, Glostrup, Denmark) and rabbit
complement by the technique of Liew & Simpson [10]. The cells
were washed three times and their viability estimated by trypan
blue dye exclusion. The cells were counted and cultured. One
set of cultures was inoculated with DV and the controls with
NMB. The cultures were harvested at 24, 48, 72 and 96 h and
the culture supernatants (CS) and cells were collected for
screening for the presence of hCF.
Preparation of cell cultures
The PBMC or its enriched subpopulation of cells (1 x 106 cell/
ml) were cultured in MEM containing 5% FCS using 4-cm
Petri dishes (Nunclon; Nunc). The cultures were inoculated
with 1000 LD50 of DV, and the control cultures with NMB;
tubes were incubated at 37°C in the presence of 5% CO2 for
various time periods. All the cultures were set in triplicate and
the experiments repeated at least three times. CS were tested for
the presence ofhCF by cytotoxicity, ELISA and dot blot assay.
The cells were processed to isolate total RNA for Northern blot
test to screen the presence of hCF-specific mRNA.
Assay of cytotoxic activity
The cytotoxic activity of preparations was assayed using
normal mouse spleen cells as target. Spleen cells were teased
out in cold MEM to make a single-cell suspension and
nucleated viable cells were counted by the trypan blue dye
exclusion test. The technique for the assay of cytotoxic activity
of CF is described elsewhere [1]. Briefly, 100 p1 of the test
solution were mixed with 100 I1 of target cells (2 x 106 cells) in
96-well perspex plate and kept at 40C for 1 h. Viability of cells
was assayed by trypan blue dye exclusion and the percentage of
non-viable cells was calculated. The data were presented after
deduction of the background values obtained from uninocu-
lated controls.
ELISA
The technique of Voller et al. [11] was used with some modi-
fications to set up ELISA for detection of CF (Mukerjee et al.,
in preparation). Briefly, a polystyrene flat-bottomed microtitre
plate (Titertek Immuno assay plate 77-173-05; Flow Labora-
tories, Zwanenburg, The Netherlands) was coated with 1:5000
dilution of mouse CF-specific antibody [3,4] in PBS overnight
at 40C. The plate was washed three times with PBS pH 7-2
containing 0 05% Tween-20 (PBS-T) and blocked with 1%
milk protein (Lactogen-I milk powder; Nestle India Ltd, New
Delhi, India) in PBS for 1 h. The plate was washed again three
times with PBS-T, and 100 1ld of the test samples were added
and the plate was incubated at 370C for 1 h. After washing of
the plate, 100 pl of protein-A conjugated with horseradish
peroxidase (HRP; a gift from the National Institute of Immu-
nology, New Delhi, India) diluted 1:10 000 in dilution buffer
(blocking buffer plus 0 5% Tween-20) were added and incu-
bated at 370C for 1 h. The plate was washed three times and
colour was developed by addition of 100 I1 of mixture of o-
phenylene diamine (OPD; Sigma Chemical Co., St Louis, MO)
and H202 in citrate buffer (0-02 M) pH 5 0. The plate was
incubated at room temperature for about 10 min and reaction
was stopped with 50 I1 of 25 N H2SO4 and absorbance was
read at 492 nm in an Automated Microplate Reader (EL 31 1 sx;
Bio-Tek Instruments Inc., USA). The following controls were
included: (i) known mouse CF as positive control; (ii) a
heterologous cytokine (suppressor cytokine) as negative con-
trol. The optical density (OD) from wells coated with the
antibody without addition of any antigen was considered as
100% binding of the protein A + HRP, while wells without
antibody coating yielded values for the blank. hCF present in
the test sample bound with the antibody on the solid phase and
inhibited subsequent binding of the protein A + HRP, thus
indicating presence of hCF. The percentage inhibition was
calculated as follows: per cent inhibition = 100 - (OD with
test samples - OD of blank)/(OD without test sample - OD of
blank) x 100.
Immunoblotting
Culture supernatants were blotted on nitrocellulose (NC) paper
in a Milliblot System (Millipore Corporation, Bedford, MA).
Some of the representative samples were resolved on 12-5%
polyacrylamide gel at a constant current of 30 mA in a vertical
slab gel system (Pharmacia, Uppsala, Sweden) and electro-
blotted (Novablot Electrophoretic Transfer Kit; Pharmacia)
onto NC paper. The blots were air-dried and blocked overnight
at 40C in 3% bovine serum albumin (BSA) prepared in 0 1 M
Tris HCl pH 7-5. After three washings with PBS-T, NC paper
was incubated with mouse CF-specific antibody (1:500 dilution
in PBS-T) for 1 h on a rocking platform at room temperature.
The NC paper was washed again three times with PBS-T and
incubated with anti-mouse IgG linked to HRP (1:500 in PBS-
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T) for 1 h at room temperature. After extensive washing the
blots were developed using diamino benzidine (Sigma) and
hydrogen peroxide. For control the blots were treated with
anti-DV antisera or normal mouse sera in place of anti-CF
antisera.
End-labelling of oligonucleotides
The two oligomers used were: 5' TGG CTC TAG ACA 3' and
5' TGG TTC TAG ACA 3'. The sequence of the above
oligomers was chosen from the N'-terminal sequence of
mouse CF [5] and was prepared by CSIR Biochemical Bio-
technology (New Delhi, India). To 1 pl of the oligomer was
added 10 x kinase buffer containing cocktail of dNTPs, T4-
polynucleotide kinase, water and 30 ACi 32P--yATP, final
volume 10 p1 [13]. The mixture was incubated at 370C for 30
min and then loaded on a Sephadex G25 column. The labelled
oligonucleotides were recovered from the column with water
and tested for specific radioactivity.
RNA isolation and Northern blot analysis
At different time periods after exposure of leucocytes, T
lymphocytes and B lymphocytes from human blood to DV,
total RNA was isolated by acid guanidinium-thiocyanate-
phenol-chloroform extraction method, as described by Chomc-
zynski & Sacchi [12]. The RNA was quantified spectrophoto-
metrically and its integrity examined by electrophoresis.
For Northern blot analysis, 20 pg of total RNA per lane
from each group was applied and separated by electrophoresis
on 1% agarose gel under denaturing conditions [13]. The RNA
was then transferred to NC membrane using the LKB Vaccu-
gene blotting system. RNA was immobilized on NC membrane
by vacuum baking at 80'C for 2 h. The blots were prehybri-
dized for 4 h at room temperature in presence of saline sodium
citrate buffer (SSC, 5 x ), 5 x Denhardt's solution, 1 mM
EDTA, and were subsequently hybridized in the same mixture
containing 32P-labelled oligonucleotides for 15 h at 42°C under
gentle shaking [13,14]. After hybridization, the NC membrane
was washed three times for 10 min at 42°C in 2 x SSC and 0 2%
SDS, and three times for 20 min in 0 1 x SSC and 0 1% SDS.
The NC membrane was exposed at -70°C to Kodak x-ray film
with intensifying screen. Autoradiograms were developed 7- 10
days after exposure. For dot blot analysis 5 pg of total RNA
were blotted directly onto NC membrane in a Milliblot System
(Millipore Corporation) and hybridized as described above.
Statistical analysis
Data were analysed using Student's t-test. P < 0 05 was con-
sidered significant.
RESULTS
Detection ofhCF by cytotoxic activity
A peak cytotoxicity of 39 + 7% was observed in the CS
collected at 48 h following DV inoculation in PBMC cultures.
At later periods, activity was slightly reduced (P > 0 05). A
peak activity of 7 + 2% was observed in culture inoculated with
NMB (Fig. la). Activity in CS from enriched DV-inoculated T
cell was little less, maximum being 29 5% (Fig. Ib), while CS
from B cells or monocyte-enriched cultures had no cytotoxic
activity (Fig. lc,d).
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Fig. 1. Cytotoxic effect of culture supernatants (CS) from human
peripheral blood mononuclear cells (PBMC) stimulated by dengue
virus (DV) in vitro at different periods after virus infection. Cultures
(1 x 106 cells/ml) were prepared in 4-cm Nunc Petri dishes ofPBMC (a)
or its enriched subpopulations of T cells (b), B cells (c) or monocytes
(d). One set of cultures was inoculated with DV (n), the second set with
normal mouse brain homogenate (NMB) (U) and the uninoculated
cultures were put up for blank. All cultures were incubated at 37°C in
5% CO2 and harvested at different periods. The CS were assayed for
cytotoxic activity using single-cell suspension of normal mouse spleen.
The cells made non-viable after 1 h incubation at 4°C were counted
using trypan blue dye exclusion. The results have been presented, after
deduction of background values, as mean ± s.d. from nine to 15
observations for each group.
Detection ofhCF by ELISA
An inhibition ELISA done to detect the presence ofCF in CS of
DV-inoculated cultures showed a peak inhibition of48 + 5% at
48 h in PBMC (Fig. 2a). A similar pattern was seen with CS
from T cell-enriched cultures (Fig. 2b), while CS from B cells or
monocyte-enriched cultures had insignificant (P > 0 5) inhibi-
tory activity (Fig. 2c,d).
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Fig. 2. Inhibition ELISA to detect the presence of cytotoxic factor (CF)
in culture supernatants (CS) from peripheral blood mononuclear cell
(PBMC) cultures. The groups of cells and the symbols are as in Fig. 1.
The plate coated with anti-CF antibody was incubated with CS from
different groups. After washing it was incubated with protein A
conjugated with horseradish peroxidase (HRP), followed by addition
of o-phenylenediamine. OD was taken at 492 nm. Controls included
mouse CF (positive control), a heterologous protein (negative control).
Inhibition of the binding of protein A + HRP by the presence of CF in
the CS was calculated from OD in the wells to which no protein was
added, as described in Materials and Methods.
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Fig. 3. Dot blot test for detection of cytotoxic factor (CF) in culture
supernatants (CS) of the cultures of peripheral blood mononuclear cells
(PBMC) or its enriched cell subpopulation as described in Fig. 1. CS
were blotted on nitrocellulose paper. The blots were treated with anti-
CF antibody followed by anti-mouse IgG + horseradish peroxidase
(HRP) and then the substrate diamino benzidine as described in
Materials and Methods. Some of the representative reactions are
shown at 24 h (row A), 48 h (row B), 72 h (row C) and 96 h (row D)
after infection; negative control (lane 9, B,C) and positive control
mouse CF (lane 9, D); CS from dengue virus (DV)-inoculated T cells
(lane 2), PBMC (lane 4), B cells (lane 6), monocytes (lane 8); CS from
normal mouse brain homogenate (NMB)-inoculated culture of T cells
(lane 1), PBMC (lane 3), B cells (lane 5) and monocytes (lane 7).
Detection ofhCF by immunoblotting
All the CS collected from different experiments were screened in
a dot blot test using anti-CF antibody. It was observed that CS
from DV-stimulated cultures of PBMC or enriched T cells at
48-96 h reacted positively, while the reaction was negligible at
24 h. CS from controls, B cells and monocyte-enriched cultures
did not show any reaction. Some of the representative reactions
are shown in Fig. 3. The data presented in Fig. 4 show the
reaction of the representative samples of each group in a
Western blot test. The anti-CF antibody reacted with mouse
CF (lane 1) and CS from DV-stimulated T cells (lane 5) and
PBMC (lane 7) cells, but not with those of B cells (lane 3) and
controls. Further, the migration of human CF was similar to
that of mouse CF (Fig. 4).
hCF production by antibody-treated cells
The findings presented in Fig. 5 show that production of hCF
was abolished by pretreatment of the T-enriched cells with anti-
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Fig. 4. Western blot analysis of some of the representative samples of
culture supernatants (CS; as in Fig. 1) collected 48 h after dengue virus
(DV) infection or normal mouse brain homogenate (NMB) inoculation.
The samples resolved on PAGE were blotted on nitrocellulose paper
and the blots were treated as in Fig. 3. The samples included were
negative control (lane 1), pure mouse cytotoxic factor (CF) (lane 2),
NMB-inoculated T cells (lane 3), DV-inoculated T cells (lane 4), NMB-
inoculated peripheral blood mononuclear cells (PBMC) (lane 5), DV-
inoculated PBMC (lane 6), NMB-inoculated PBMC (lane 7), DV-
inoculated B cells (lane 8), DV-inoculated monocytes (lane 9).
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Fig. 5. Cytotoxic effect of culture supernatants (CS) from T-enriched
cells pretreated with anti-CD4 or anti-CD8 antibody and complement.
After washing, one set of the cells was inoculated with dengue virus
(DV) (0), the second set with normal mouse brain homogenate (NMB)
(E) and the third set was an uninoculated control for blank. The
cultures were incubated at 37°C in presence of 5% CO2 for 48 h and
the CS were collected. Cytotoxic activity of the CS was assayed as in
Fig. 1. The mean value ± s.d. from 15 observations of each sample is
presented.
CD4 antibodies as shown by cytotoxicity assay (6 ± 2%).
Treatment with anti-CD8 antibodies had no effect on the
production of hCF (cytotoxicity 31 ± 7%). Similar findings
were observed when the CS from this experiment was assayed
by ELISA for the presence of hCF (data not shown).
Detection ofmRNA for hCF
Autoradiograms of the Northern blot and dot blot analysis of
mRNA for hCF are presented in Fig. 6a,b. A positive reaction
with CF-specific oligonucleotide probe was observed with
DV-stimulated PBMC and T cells, but not with B cells. A
faint reaction was observed with control T cells and PBMC
(Fig. 6a).
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Fig. 7. Dengue virus titres in the culture supernatants (CS) of peripheral
blood mononuclear cell (PBMC) cultures at different periods after virus
inoculation. Each point represents an average for three CS.~~~~~~~~~~~~~~~~~~~~~~~~~~~....-....
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Fig. 6 (a) Northern blot analysis of total RNA isolated from dengue
virus (DV)-infected T cells (lane 3) and peripheral blood mononuclear
cell (PBMC) (lane 4) cultures normal mouse brain homogenate
(NMB)-inoculated T cells (lanes 1,2) and also PBMC (lane 5,6)
cultures. Hybridization was done as described in Materials and Meth-
ods after size separation of 20 yg RNA on agarose gel and then blotting
on nitrocellulose (NC) membrane. (b) Dot blot analysis of total RNA
isolated from DV-infected T cells (lanes 1,2); PBMC (lane 3); B cells
(lanes 4,5) and monocyte (lane 6,7) cultures. For controls RNA isolated
from DV-infected mouse spleen was used as positive control (lane 8).
Each spot represents 5 jtg of RNA from one culture or one mouse
spleen. Hybridization was done as described in Materials and Methods.
Detection of D V replication in MNC cultures
The average titres of the virus in the supernatants of three
PBMC cultures at different time periods are shown in Fig. 7.
The virus titre was highest at 48 h after DV infection.
DISCUSSION
The significant finding of the present study is that human T cells
are capable of producing hCF on stimulation by DV in vitro.
The presence of hCF in CS of DV-stimulated cultures was
demonstrated by ELISA and cytotoxicity assay, and was
further confirmed by dot blot and Western blot tests and
demonstration of CF-specific mRNA by Northern blot tests.
Recently, presence of CF has been shown in the sera of few
DHF patients collected during the Shahjahanpur epidemic in
1993. This finding was validated at US Army Medical Compo-
nent (AFRIMS, Bangkok, Thailand) by screening 340 sera
from cases of dengue disease. We have succeeded in purifying
CF proteins from the sera of human cases of DHF collected at
Shahjahanpur, by ion exchange and affinity chromatography
(U.C. Chaturvedi et al., manuscript in preparation). This
indicated that a protein which is pathogenesis-related in mice
is also present in human cases and may explain some aspects of
pathogenesis of the human disease.
An effort was made to identify the cell type in human
peripheral blood leucocytes, responsible for the production of
CF on stimulation by DV. It was observed that T cells were
responsible for the production of hCF. The findings of the
following experiments supported this conclusion on the basis of
ELISA and cytotoxicity assay: (i) CF activity was similar in the
CS from T cell-enriched (monocyte- and B cell-depleted) and
PBMC subpopulation (P > 0 05); (ii) CS from B cell-enriched
population had no activity; (iii) CS from monocyte-enriched
population had no hCF activity. These findings were confirmed
by dot blot test also. Treatment of T cells with anti-CD4
antibody and complement abrogated the production of hCF,
while treatment with anti-CD8 antibody and complement had
no effect. This strongly suggested that hCF was produced by
CD4 + T cells. This is similar to the mouse CF which is
produced by L3T4 + splenic T cells ([1,15], unpublished data).
Further, the expression of mRNA in PBMC and T cells
reflected synthesis of hCF by the cells following stimulation
by DV. Detection of a cytokine by expression of mRNA is a
much more sensitive and specific technique, and has been used
in PBMC by in situ hybridization [16].
The virus antigen is detectable in the spleen of mice,
inoculated intracerebrally with DV by immunofluorescence
from day 4 and the titre of the virus reaches peak levels from
day 8 [17]. The CF is detectable in the spleens of such mice from
day 6, reaching peak cytotoxic activity on days 10-11 [1]. In the
present study DV was detectable throughout the period of
study, with peak virus titres at 48 h, and the hCF was detected
at 48 h after DV inoculation in the cultures and persisted to
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similar levels up to hour 96 of the study. On the other hand,
PBMC cultures inoculated with heat-killed DV showed neither
the virus nor the production of hCF (data not shown). A
similar time schedule is observed when mouse spleen cell
cultures are infected with DV (unpublished data). DV has
been shown to replicate in vitro in B-type lymphoblastoid
cells; in mitogen-stimulated peripheral blood lymphocytes; in
macrophages; and possibly in specifically sensitized lympho-
cytes (reviewed in [18]). It has been observed that the presence
of macrophages is obligatory for the presentation of DV
antigen to B cells, leading to their clonal expansion and
consequent immune response. The B cells as such are incapable
of receiving the native DV antigen [19,20]. The findings of the
present study show that induction of hCF production by DV
does not require any accessory cells; DV could directly stimu-
late T cells to produce hCF (Fig. lb, 2b).
Mouse CF is a pathogenesis-associated protein and is
capable of reproducing all the pathological lesions in mice
that are seen in cases of DHF, e.g. increase in vascular perme-
ability, cerebral oedema, and alterations in leucocyte number
and functions [2,3,18]. Mouse and hCF have shown a number
of similarities, namely (i) hCF could be detected in ELISA, dot
blot and Western blot by anti-mouse CF antisera; (ii) the
electrophoretic migration of both the CF is the same, as
shown in the Western blot test (Fig. 4); (iii) mRNA for hCF
could be detected by oligonucleotide probes derived from the
amino acid sequence of mouse CF; and (iv) cytotoxic activity
on normal mouse spleen cells is similar by both of them. Efforts
are being made to purify and determine the amino acid
sequence of hCF so that its homology (if any) with mouse
CF is determined. This will also explain the presence of cross-
reacting antigens on the mouse CF and hCF. The cDNA
library for mouse CF has been constructed and the recombi-
nant CF has been expressed in Escherichia coli (U.C. Chatur-
vedi et al., manuscript in preparation). There is a need to
produce larger quantities of hCF so that it may be character-
ized fully.
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